AC Immune S.A. Statistics Share Statistics AC Immune S.A. has 98.94M
shares outstanding. The number of shares has increased by -0.74%
in one year.
Shares Outstanding 98.94M Shares Change (YoY) -0.74% Shares Change (QoQ) 0% Owned by Institutions (%) 25.81% Shares Floating 61.06M Failed to Deliver (FTD) Shares 4,446 FTD / Avg. Volume 3.24%
Short Selling Information The latest short interest is 1.4M, so 1.4% of the outstanding
shares have been sold short.
Short Interest 1.4M Short % of Shares Out 1.4% Short % of Float 2.95% Short Ratio (days to cover) 11.36
Valuation Ratios The PE ratio is -4.8 and the forward
PE ratio is -4.86.
AC Immune S.A.'s PEG ratio is
0.24.
PE Ratio -4.8 Forward PE -4.86 PS Ratio 8.95 Forward PS 4 PB Ratio 2.18 P/FCF Ratio 3.74 PEG Ratio 0.24
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AC Immune S.A..
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.71,
with a Debt / Equity ratio of 0.05.
Current Ratio 1.71 Quick Ratio 1.71 Debt / Equity 0.05 Debt / EBITDA -0.11 Debt / FCF 0.08 Interest Coverage -393.82
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $205.33K Profits Per Employee $-382.83K Employee Count 133 Asset Turnover 0.12 Inventory Turnover n/a
Taxes Income Tax 3K Effective Tax Rate -0.01%
Stock Price Statistics The stock price has increased by -39.53% in the
last 52 weeks. The beta is 1.65, so AC Immune S.A.'s
price volatility has been higher than the market average.
Beta 1.65 52-Week Price Change -39.53% 50-Day Moving Average 2.06 200-Day Moving Average 2.36 Relative Strength Index (RSI) 49.11 Average Volume (20 Days) 137,024
Income Statement In the last 12 months, AC Immune S.A. had revenue of 27.31M
and earned -50.92M
in profits. Earnings per share was -0.51.
Revenue 27.31M Gross Profit 27.31M Operating Income -52.38M Net Income -50.92M EBITDA -48.62M EBIT -50.78M Earnings Per Share (EPS) -0.51
Full Income Statement Balance Sheet The company has 36.27M in cash and 5.43M in
debt, giving a net cash position of 30.85M.
Cash & Cash Equivalents 36.27M Total Debt 5.43M Net Cash 30.85M Retained Earnings -368.24M Total Assets 211.08M Working Capital 52.89M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 65.84M
and capital expenditures -576K, giving a free cash flow of 65.27M.
Operating Cash Flow 65.84M Capital Expenditures -576K Free Cash Flow 65.27M FCF Per Share 0.65
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -191.8% and -186.44%.
Gross Margin 100% Operating Margin -191.8% Pretax Margin -186.43% Profit Margin -186.44% EBITDA Margin -178.03% EBIT Margin -191.8% FCF Margin 238.99%
